Literature DB >> 29327059

Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation.

Allison M Martin1, Daniel N Cagney1, Paul J Catalano2,3, Brian M Alexander1, Amanda J Redig4, Jon D Schoenfeld1, Ayal A Aizer1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29327059      PMCID： PMC5885198          DOI： 10.1001/jamaoncol.2017.3993

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.

Authors:  Kim Margolin; Marc S Ernstoff; Omid Hamid; Donald Lawrence; David McDermott; Igor Puzanov; Jedd D Wolchok; Joseph I Clark; Mario Sznol; Theodore F Logan; Jon Richards; Tracy Michener; Agnes Balogh; Kevin N Heller; F Stephen Hodi
Journal:  Lancet Oncol       Date:  2012-03-27       Impact factor: 41.316

2.  Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids.

Authors:  François Chasset; Cécile Pages; Lucie Biard; Jennifer Roux; Irina Sidina; Isabelle Madelaine; Nicole Basset-Seguin; Manuelle Viguier; Nika Madjlessi-EzrA; Pierre Schneider; Martine Bagot; Matthieu Resche-Rigon; Céleste Lebbe
Journal:  Eur J Dermatol       Date:  2015 Jan-Feb       Impact factor: 3.328

Review 3.  Cerebral radiation necrosis.

Authors:  Pierre Giglio; Mark R Gilbert
Journal:  Neurologist       Date:  2003-07       Impact factor: 1.398

4.  Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.

Authors:  Sarah B Goldberg; Scott N Gettinger; Amit Mahajan; Anne C Chiang; Roy S Herbst; Mario Sznol; Apostolos John Tsiouris; Justine Cohen; Alexander Vortmeyer; Lucia Jilaveanu; James Yu; Upendra Hegde; Stephanie Speaker; Matthew Madura; Amanda Ralabate; Angel Rivera; Elin Rowen; Heather Gerrish; Xiaopan Yao; Veronica Chiang; Harriet M Kluger
Journal:  Lancet Oncol       Date:  2016-06-03       Impact factor: 41.316
  4 in total
  70 in total

1.  Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies.

Authors:  Ines Pires da Silva; Isabella C Glitza; Lauren E Haydu; Romany Johnpulle; Patricia D Banks; George D Grass; Simone M A Goldinger; Jessica L Smith; Ashlyn S Everett; Peter Koelblinger; Rachel Roberts-Thomson; Michael Millward; Victoria G Atkinson; Alexander Guminski; Rony Kapoor; Robert M Conry; Matteo S Carlino; Wei Wang; Mark J Shackleton; Zeynep Eroglu; Serigne Lo; Angela M Hong; Georgina V Long; Douglas B Johnson; Alexander M Menzies
Journal:  Pigment Cell Melanoma Res       Date:  2019-03-03       Impact factor: 4.693

2.  Local control after brain-directed radiation in patients with cystic versus solid brain metastases.

Authors:  Rachel H Brigell; Daniel N Cagney; Allison M Martin; Luke A Besse; Paul J Catalano; Eudocia Q Lee; Patrick Y Wen; Paul D Brown; John G Phillips; Itai M Pashtan; Shyam K Tanguturi; Daphne A Haas-Kogan; Brian M Alexander; Ayal A Aizer
Journal:  J Neurooncol       Date:  2019-02-04       Impact factor: 4.130

Review 3.  The Reciprocity between Radiotherapy and Cancer Immunotherapy.

Authors:  Yifan Wang; Zhi-Gang Liu; Hengfeng Yuan; Weiye Deng; Jing Li; Yuhui Huang; Betty Y S Kim; Michael D Story; Wen Jiang
Journal:  Clin Cancer Res       Date:  2018-11-09       Impact factor: 12.531

4.  Will immunotherapy change the role of spine radiosurgery in high-grade epidural disease? A case report and a call for an update of current treatment algorithms.

Authors:  Christina Kehl Cramer; James D Ververs; Frederick Scott Jones; Wesley Hsu; Michael David Chan; Stacey Quintero Wolfe
Journal:  J Radiosurg SBRT       Date:  2019

5.  Single-fraction versus hypofractionated gamma knife radiosurgery for small metastatic brain tumors.

Authors:  Yavuz Samanci; Fatih Karakose; Sukran Senyurek; Selcuk Peker
Journal:  Clin Exp Metastasis       Date:  2021-03-17       Impact factor: 5.150

6.  CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases.

Authors:  Nicholas B Figura; Thrisha K Potluri; Homan Mohammadi; Daniel E Oliver; John A Arrington; Timothy J Robinson; Arnold B Etame; Nam D Tran; James K Liu; Hatem Soliman; Peter A Forsyth; Solmaz Sahebjam; H Michael Yu; Hyo S Han; Kamran A Ahmed
Journal:  J Neurooncol       Date:  2019-08-09       Impact factor: 4.130

Review 7.  The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer.

Authors:  Shyam Tanguturi; Laura E G Warren
Journal:  Curr Oncol Rep       Date:  2019-04-16       Impact factor: 5.075

8.  Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort.

Authors:  J Bryan Iorgulescu; Maya Harary; Cheryl K Zogg; Keith L Ligon; David A Reardon; F Stephen Hodi; Ayal A Aizer; Timothy R Smith
Journal:  Cancer Immunol Res       Date:  2018-07-12       Impact factor: 11.151

Review 9.  The Promise of Combining Radiation Therapy With Immunotherapy.

Authors:  Justin C Jagodinsky; Paul M Harari; Zachary S Morris
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-23       Impact factor: 7.038

10.  Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis.

Authors:  Jeffrey P Guenette; Raymond Y Huang; Pyeong Hwa Kim; Chong Hyun Suh; Ho Sung Kim; Kyung Won Kim; Dong Yeong Kim; Ayal A Aizer; Rifaquat Rahman
Journal:  Eur Radiol       Date:  2020-11-25       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.